CD27/TNFRSF7 ELISA DY382-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCD27/TNFRSF7 ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY382-05
NCBI Gene AliasesS152, S152. LPFS2, T14, TNFRSF7, Tp55
NCBI Full Gene NameCD27 molecule
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
Detection TargetCD27/TNFRSF7
ReactivityHuman
Detection Range125.00 - 8000 pg/mL
ApplicationsELISA
Quantity1 Kit (for 5 Plates)

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 5 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHDBlood AdvancesSeptember 24, 2024Kriti Verma, Wayne Croft, Sandra Margielewska-Davies, Hayden Pearce, Christine Stephens, Diana Diaconescu, Sarah Bevington, Charles Craddock, Rasoul Amel-Kashipaz, Jianmin Zuo, et al.supplemental Data. Enzyme-linked immunosorbent assay Human CD27 Duoset enzyme-linked immunosorbent assay (DY382-05; R&D systems) was used to quantify the concentration of soluble CD27 in the serum of patients who underwent

(2) Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosisJournal of neuroinflammationApril 12, 2024Cencioni MT, Magliozzi R, Palmisano I, Suwan K, Mensi A, Fuentes-Font L, Villar LM, Fernández-Velasco JI, Migallón NV, Costa-Frossard L, et al.

(3) Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotypeFrontiers in immunologyJanuary 1, 2024Ansari AW, Jayakumar MN, Ahmad F, Venkatachalam T, Salameh L, Unnikannan H, Raheed T, Mohammed AK, Mahboub B, Al-Ramadi BK, et al.−20°C until use. sCD27 protein levels were quantified using human CD27/TNFRS7 DuoSet ELISA kit (Cat# DY382–05, R&D Systems, USA) as per manufacturer’s instructions. All the samples were used in duplicates, and

(4) CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisNeurology - Neuroimmunology NeuroinflammationSeptember 1, 2023Katarina Lundblad, Christina Zjukovskaja, Anders Larsson, Honar Cherif, Kim Kultima, Joachim Burmanconcentrations of CXL13 and sCD27 were analyzed with commercial ELISA (R&D systems, Minneapolis, MN; catalogue# DY382-05 and DCX130) according to the manufacturer's instructions. Undiluted samples were run in duplex on each

(5) CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisNeurol Neuroimmunol NeuroinflammJune 13, 2023Katarina Lundblad, Christina Zjukovskaja, Anders Larsson, Honar Cherif, Kim Kultima, Joachim Burmanconcentrations of CXL13 and sCD27 were analyzed with commercial ELISA (R&D systems, Minneapolis, MN; catalogue# DY382-05 and DCX130) according to the manufacturer's instructions. Undiluted samples were run in duplex on each

(6) Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patientsScientific reportsMarch 31, 2022Carbone ML, Madonna G, Capone A, Bove M, Mastroeni S, Levati L, Capone M, Ascierto PA, De Galitiis F, D'Atri S, et al.Concentrations of human CD25/IL-2 Rα (cat. no. DY223, R&D Systems, Minneapolis, USA), CD27/TNFRSF7 (cat. no. DY382-05, R&D Systems, Minneapolis, USA), IL-17A (cat. no. DY317, R&D Systems, Minneapolis, USA), S100B (cat.

(7) An openâ€label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinomaClinical and Translational ScienceNovember 1, 2021Astrid De Meulenaere, Tijl Vermassen, David Creytens, Stijn De Keukeleire, Tim Delahaye, Philippe Deron, FrÃ©deric Duprez, Samson Fung, Patrick Pauwels, Liesbeth Ferdinande, et al.=300 copies/µg DNA). The sCD27 was measured using the human CD27/TNFRSF7 DuoSet ELISA kit (cat no. DY382‐05, R&D systems) as this would give an insight into the inhibition of the CD70/CD27 axis by cusatuzumab.

(8) Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosisMultiple sclerosis journal - experimental, translational and clinicalApril 1, 2021Ioannides ZA, Csurhes PA, Swayne A, Foubert P, Aftab BT, Pender MP.using human TREM-2 DuoSet® ELISA (Cat DY1825-05), and for sCD27 using human sCD27 DuoSet® ELISA (Cat. DY382-05). Both kits were obtained from R&D Systems (Minneapolis, Minnesota, USA). For assays of NfL and NfH,

(9) Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degenerationPloS oneJanuary 1, 2020Lashkari K, Teague GC, Beattie U, Betts J, Kumar S, McLaughlin MM, López FJ.

(10) A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung CancerEBioMedicineJune 1, 2018Guo NL, Dowlati A, Raese RA, Dong C, Chen G, Beer DG, Shaffer J, Singh S, Bokhary U, Liu L, et al.tissue samples. The DuoSet ELISA Development Systems from R&D Systems (Minneapolis, MN; catalog number: DY382-05) were used for quantifying protein expression of T-Cell Activation Antigen CD27 (CD27)/Tumor Necrosis

(11) Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosisTheranosticsJanuary 1, 2018Herman S, Khoonsari PE, Tolf A, Steinmetz J, Zetterberg H, Åkerfeldt T, Jakobsson PJ, Larsson A, Spjuth O, Burman J, et al.

Be the First to Write a Review!

CD27/TNFRSF7 ELISA

CD27/TNFRSF7 ELISA

CD27/TNFRSF7 ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (11)

Reviews

CD27/TNFRSF7 ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map